Bank Of America Corp Celldex Therapeutics, Inc. Transaction History

Bank Of America Corp

  • $1.21 Trillion
  • Q1 2025

A detailed history of Bank Of America Corp transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 244,936 shares of CLDX stock, worth $4.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,936
Previous 42,848 471.64%
Holding current value
$4.84 Million
Previous $1.08 Million 310.81%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$18.15 - $27.6 $3.67 Million - $5.58 Million
202,088 Added 471.64%
244,936 $4.45 Million
Q4 2024

Feb 14, 2025
SELL
$23.31 - $32.4 $4.09 Million - $5.69 Million
-175,590 Reduced 80.38%
42,848 $1.08 Million
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $919,256 - $1.28 Million
-28,673 Reduced 11.6%
218,438 $7.42 Million
Q2 2024

Aug 14, 2024
SELL
$32.76 - $42.56 $802,620 - $1.04 Million
-24,500 Reduced 9.02%
247,111 $9.15 Million
Q1 2024

May 15, 2024
BUY
$35.22 - $51.88 $1.89 Million - $2.79 Million
53,797 Added 24.7%
271,611 $11.4 Million
Q4 2023

Feb 14, 2024
SELL
$22.61 - $40.65 $3.1 Million - $5.57 Million
-137,107 Reduced 38.63%
217,814 $8.64 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $199,792 - $252,494
-6,596 Reduced 1.82%
354,921 $12 Million
Q1 2023

May 12, 2023
BUY
$34.78 - $47.43 $7.24 Million - $9.88 Million
208,217 Added 135.82%
361,517 $13 Million
Q4 2022

Feb 10, 2023
BUY
$27.78 - $45.38 $619,771 - $1.01 Million
22,310 Added 17.03%
153,300 $6.83 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $1.12 Million - $1.85 Million
49,268 Added 60.29%
130,990 $3.68 Million
Q2 2022

Aug 12, 2022
SELL
$20.5 - $37.33 $2.03 Million - $3.7 Million
-99,172 Reduced 54.82%
81,722 $2.2 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $2.39 Million - $3.4 Million
86,457 Added 91.55%
180,894 $6.16 Million
Q4 2021

Feb 08, 2022
BUY
$35.68 - $56.27 $2.43 Million - $3.83 Million
68,077 Added 258.26%
94,437 $3.65 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $395,688 - $765,271
13,668 Added 107.69%
26,360 $1.42 Million
Q2 2021

Sep 13, 2021
BUY
$20.71 - $35.37 $262,851 - $448,916
12,692 New
12,692 $425,000

Others Institutions Holding CLDX

# of Institutions
188
Shares Held
69.3M
Call Options Held
220K
Put Options Held
310K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $925M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email